Child Neurology Residency Training Program HMS Longwood Medical Area

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Boston Children's Hospital is the primary pediatric program of Harvard Medical School, which is located next to the hospital. All faculty hold academic appointments at the medical school. There are more than 500 Harvard Medical School faculty at Boston Children's Hospital.

Boston Children's Hospital and Harvard Medical School are part of a larger, roughly 20 square block campus called the Longwood Medical Area. Children's sits in the center of this area, adjacent to then Brigham and Women's Hospital, Beth Israel Deaconess Medical Center and the Dana-Farber Cancer Institute, as well as Harvard Medical School, and within a block of the Joslin Diabetes Center, the Massachusetts College of Pharmacy, the Harvard School of Public Health, the Harvard Dental School, the Channing Laboratory, and the Immune Disease Institute. Some members of the staff are also staff members at one of these neighboring institutions.

Boston Children's Hospital participates in numerous cooperative programs. It is a partner in Neonatology with Brigham and Women's Hospital and Beth Israel Deaconess Medical Center.

It is the headquarters of the New England Regional Infant Cardiac Program, the site of the Massachusetts Poison Control System, a partner in the Joint Program in Pediatric Hematology/Oncology with Dana-Farber Cancer Institute and a partner in the Joint Program in Gastroenterology and Nutrition with Massachusetts General Hospital across town. Several surgical departments are joint programs with the Brigham and Women's Hospital.

Recently, the Immune Disease Institute has joined with Boston Children's Hospital to become the Program in Cellular and Molecular Medicine. The IDI/PCMM, which originated at Boston Children's Hospital as the Blood Grouping Laboratory, is, in a sense, coming home. The Program has 19 principal investigators and 200 staff who pursue basic research in four principal areas: adhesion molecules and inflammation, autoimmune and allergic disease, genetics of immunodeficiency and cancer, and immune defenses against infectious disease and tumors.

The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO
Close